The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)
The article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid. Scientific data on the prevalence of bullous dermatoses in the Russian Federation (true pemphigus, Lever's bullous pemph...
Guardado en:
Autores principales: | Andrey A. Martynov, Anna V. Vlasova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
State Scientific Center of Dermatovenereology and Cosmetology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47714a7bc49b4368a01a2093988f20b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Vito Di Lernia, et al.
Publicado: (2020) -
Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Anna Rosińska-Więckowicz, et al.
Publicado: (2021) -
Bullous pemphigoid induced by Hijama therapy (cupping)
por: Arghavan Azizpour, et al.
Publicado: (2018) -
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020) -
Successful induction treatment of bullous pemphigoid using reslizumab: a case report
por: Hyo-In Rhyou, et al.
Publicado: (2021)